AC Immune (ACIU) Return on Capital Employed Growth (5y) (2021 - 2026)

AC Immune (ACIU) Return on Capital Employed Growth (5y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,561.01 Bn 66,560.72 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn -
4 BeOne Medicines 469.79 Bn 465.00 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.95 Bn 115.70 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.30 Bn 3.31 Bn
7 Belite Bio 62.62 Bn 62.62 Bn -
8 Argenx Se 56.18 Bn 50.99 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 AC Immune 227.70 Mn 227.70 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.00
Dec 31, 2025 2,578.00
Sep 30, 2025 -6,328.00
Jun 30, 2025 -4,243.00
Mar 31, 2025 -3,344.00
Dec 31, 2024 -3,719.00
Sep 30, 2024 -2,686.00
Jun 30, 2024 -5,835.00
Mar 31, 2024 -4,588.00
Mar 31, 2022 660,102.00
Dec 31, 2021 477.00